New brain imaging tech could revolutionize PTSD treatment dosing
NCT ID NCT05916417
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new method to personalize TMS (a non-invasive brain stimulation) dosing for people with PTSD, with or without mild traumatic brain injury. Researchers will use brain imaging (fNIRS) to measure brain activity directly, aiming to replace the current indirect method. Sixty adults aged 18-70 will participate to see if this approach is feasible and accurate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcranial Magnetic Stimulation (TMS) device
- What this could lead to
- If successful, this could lead to more precise TMS dosing for PTSD and TBI, potentially improving treatment outcomes.
- What could go wrong
- This is an early feasibility study with only 60 participants, so results may not apply broadly. The technology is still experimental.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Isabelle Taylor
RECRUITINGTallahassee, Florida, 32306, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could music be medicine for the injured brain?
- Can blood markers predict brain injury outcomes?
- Can a treadmill that adapts to your pace fix uneven steps?
- Can brain training help TBI patients remember to remember?
- Can a natural protein fragment help the brain heal after severe injury?